McDermott Will & Emery has provided legal counsel to Lorient Capital, a private investment firm focused exclusively on the healthcare industry, in the formation of Lorient Healthcare Fund II, which closed with aggregate capital commitments of USD225 million. The McDermott team was  led by partner Ian Schwartz, head of the

With demand for litigation finance continuing to grow among businesses of all sizes, dispute funder Validity Finance has raised a new managed fund of USD70 million in capital commitments.  The newly raised “sidecar” fund further diversifies Validity’s business and advances its experience as an alternative asset manager. To date, Validity’s

Development Partners International (DPI), an investment firm focused on Africa, has raised USD900 million for African Development Partners III Fund (ADP III), exceeding its USD800 million target. The find also attracted an additional USD250 million of dedicated co-investment capital, bringing a total of USD1.15 billion for investments on the continent. 

GP Bullhound has closed its oversubscribed Fund V at the hard cap of EUR300 million. Initially targeting EUR200 million, GP Bullhound extended the fund size due to strong demand from tech entrepreneurs, family offices and institutions in Europe and the US. Moreover, 90 per cent of all Fund IV investors

Kyma Investment Partners SGR (KYMA), an asset management company with a EUR130 million target size for its first fund dedicated to the digital transformation of Italian SMEs and specific focus on Education and Information Technology, has held its first closing at around EUR100 million.  The funds were raised from primary

Advent France Biotechnology (AFB), an AMF-regulated investment company dedicated to life sciences, has held the first closing of its second fund at EUR86 million (USD102 million).  The European Investment Fund (EIF) and the Fonds national d’amorçage 2 (the French Seed Fund 2) managed on behalf of the French State by